Global Cell and Gene Therapy Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Cell and Gene Therapy Market was valued at $25.0 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 18.7% CAGR, to an estimated market size of $59.0 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global Cell and Gene Therapy (CGT) market encompasses the development, manufacturing, and commercialization of advanced therapeutics that treat or prevent diseases by modifying genetic material or transplanting live cells. This includes CAR-T cell therapies, gene editing technologies like CRISPR, and both viral and non-viral vectors, while excluding traditional pharmaceuticals and standard biologics.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Cell and Gene Therapy Market in the period 2025-30:
- The integration of Artificial Intelligence and machine learning is accelerating drug discovery and optimizing complex manufacturing logistics for personalized treatments.
- A strategic industry shift from autologous to allogeneic (off-the-shelf) therapies is underway to enhance scalability and reduce the high cost per patient.
- Clinical development is rapidly expanding beyond blood cancers into solid tumors, targeting conditions like glioblastoma and gastric cancers.
- Regulatory agencies are increasingly adopting expedited approval pathways, such as the RMAT designation, to bring life-saving therapies to market faster.
- The high cost of treatment, often exceeding $1 million, is driving the need for innovative reimbursement models and value-based pricing strategies.
- Biotech firms are increasingly reliant on CDMOs to provide the specialized GMP-compliant infrastructure required for viral vector production.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Cell Therapy
- Gene Therapy